University of Colorado, Aurora, Colorado, USA.
University of Michigan, Ann Arbor, Michigan, USA.
Health Econ. 2024 Jun;33(6):1211-1228. doi: 10.1002/hec.4810. Epub 2024 Feb 15.
Despite the growing need for surrogate decision-making for older adults, little is known about how surrogates make decisions and whether advance directives would change decision-making. We conducted a nationally representative experimental survey that cross-randomized cognitive impairment, gender, and characteristics of advance care planning among hospitalized older adults through a series of vignettes. Our study yielded three main findings: first, respondents were much less likely to recommend life-sustaining treatments for patients with dementia, especially after personal exposure. Second, respondents were more likely to ignore patient preferences for life-extending treatment when the patient had dementia, and choose unwanted life-extending treatments for patients without dementia. Third, in scenarios where the patient's wishes were unclear, respondents were more likely to choose treatments that matched their own preferences. These findings underscore the need for improved communication and decision-making processes for patients with cognitive impairment and highlight the importance of choosing a surrogate decision-maker with similar treatment preferences.
尽管老年人对代理决策的需求不断增长,但对于代理人如何做出决策以及预先指示是否会改变决策,人们知之甚少。我们进行了一项全国性的代表性实验调查,通过一系列情景随机交叉了认知障碍、性别以及预先护理计划的特征在住院老年人中的作用。我们的研究有三个主要发现:首先,对于痴呆症患者,被调查者建议进行维持生命治疗的可能性要小得多,尤其是在个人接触之后。其次,当患者患有痴呆症时,被调查者更有可能忽视患者对延长生命治疗的偏好,而选择不希望对没有痴呆症的患者进行延长生命的治疗。第三,在患者意愿不明确的情况下,被调查者更有可能选择与自己偏好相符的治疗方法。这些发现强调了需要为认知障碍患者改善沟通和决策过程,并突出了选择具有相似治疗偏好的代理人的重要性。